Please wait...
About This Project
70% of breast cancers are estrogen receptor α (ERα)-positive. ERα is the antenna that senses the ovarian hormone estrogen (E2) and drives tumour cell proliferation and spreading. 4OH-tamoxifen and faslodex are given to patients to prevent cancer growth and spreading but they possess serious side effects. Thus, additional drugs are needed to fight breast cancer. We will explore existing drugs for the possibility of ‘reuse’ as breast cancer drugs.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Do fungi exposed to toxic waste produce novel antimicrobial agents?
We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...
Development of non-invasive diagnostics for endotheliotropic herpesvirus in free-ranging Asian elephants
Elephant endotheliotropic herpes virus hemorrhagic disease (EEHV-HD) is the leading cause of death of young...